JP2017519801A - 犬糸状虫に対する駆虫薬の使用 - Google Patents

犬糸状虫に対する駆虫薬の使用 Download PDF

Info

Publication number
JP2017519801A
JP2017519801A JP2017500885A JP2017500885A JP2017519801A JP 2017519801 A JP2017519801 A JP 2017519801A JP 2017500885 A JP2017500885 A JP 2017500885A JP 2017500885 A JP2017500885 A JP 2017500885A JP 2017519801 A JP2017519801 A JP 2017519801A
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl
compound
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017500885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519801A5 (enExample
Inventor
シャセン，クリストフ・ピエール・アラン
ルッツ，ユルゲン
へクロス，アンニャ・レジーナ
Original Assignee
インターベット インターナショナル ベー． フェー．
インターベット インターナショナル ベー． フェー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー． フェー．, インターベット インターナショナル ベー． フェー． filed Critical インターベット インターナショナル ベー． フェー．
Publication of JP2017519801A publication Critical patent/JP2017519801A/ja
Publication of JP2017519801A5 publication Critical patent/JP2017519801A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2017500885A 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用 Withdrawn JP2017519801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14176737.6 2014-07-11
EP14176737 2014-07-11
PCT/EP2015/065870 WO2016005577A1 (en) 2014-07-11 2015-07-10 Use of anthelmintic agents against dirofilaria immitis

Publications (2)

Publication Number Publication Date
JP2017519801A true JP2017519801A (ja) 2017-07-20
JP2017519801A5 JP2017519801A5 (enExample) 2018-07-26

Family

ID=51167759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500885A Withdrawn JP2017519801A (ja) 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用

Country Status (7)

Country Link
US (1) US20170196854A1 (enExample)
EP (1) EP3166605A1 (enExample)
JP (1) JP2017519801A (enExample)
CN (1) CN106470683A (enExample)
AU (1) AU2015286635A1 (enExample)
BR (1) BR112017000520A2 (enExample)
WO (1) WO2016005577A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102007135B1 (ko) 2017-03-20 2019-08-02 포르마 세라퓨틱스 인크. 피루베이트 키나제 (pkr) 활성화제로서의 피롤로피롤 조성물
JOP20190223A1 (ar) 2017-04-01 2019-09-26 Novartis Ag عملية لتحضير حمض 1-(4- ميثان سلفونيل -2- تراي فلورو ميثيل - بنزيل)-2- ميثيل -1h- بيرولو [2، 3-b] بيريدين -3- يل- أسيتيك
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
EP3852791B1 (en) 2018-09-19 2024-07-03 Novo Nordisk Health Care AG Activating pyruvate kinase r
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
EP3980414A1 (en) 2019-06-07 2022-04-13 Elanco Tiergesundheit AG Bicyclic derivatives for treating endoparasites
US20220378756A1 (en) 2019-09-19 2022-12-01 Forma Therapeutics, Inc. Activating pyruvate kinase r
WO2021174069A1 (en) 2020-02-28 2021-09-02 Auburn University Dirofilaria volatile organic compound signatures and uses thereof
US12473300B2 (en) 2020-03-06 2025-11-18 Guangzhou Maxinovel Pharmaceuticals Co., Ltd. Thienopyrimidine derivative and preparation method therefor
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201041868A (en) * 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) * 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use
EP2468096A1 (en) * 2010-12-21 2012-06-27 Intervet International BV Anthelmintic combinations
AU2013348175B2 (en) * 2012-11-20 2016-11-17 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic compounds and compositions and method of using thereof

Also Published As

Publication number Publication date
BR112017000520A2 (pt) 2017-11-14
US20170196854A1 (en) 2017-07-13
EP3166605A1 (en) 2017-05-17
WO2016005577A1 (en) 2016-01-14
CN106470683A (zh) 2017-03-01
AU2015286635A1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
JP2017519801A (ja) 犬糸状虫に対する駆虫薬の使用
US10010538B2 (en) Use of anthelmintic agents against Dirofilaria immitis
US9096524B2 (en) Anthelmintic agents and their use
CN101896459B (zh) 驱肠虫药及其用途
AU2012220531B2 (en) Asymmetric ureas and medical uses thereof
EP2443091B1 (en) Anthelmintic agents and their use

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180615

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180615

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20181213